The Geneith Health Competition (GHC) is expanding its malaria advocacy campaign across Nigeria, with registration reopened for Batch B following increased participation from secondary schools and tertiary institutions. The Managing Director of CEOAFRICA and initiator of GHC, Prince Cletus Ilobanafor, emphasized that equipping young people with accurate health information is crucial for sustainable malaria control. He stressed that health education must go beyond classroom instruction to inspire practical action and responsible health decisions.

The GHC has announced November 20, 2026, as the commencement date for the Batch A Malaria Ambassador Training, a nine-day intensive program designed to equip students with knowledge and leadership skills to promote malaria prevention and public health awareness. The initiative, organized by CEOAFRICA and sponsored by Geneith Pharmaceuticals, aims to mobilize Nigerian students as advocates in the fight against malaria. The program seeks to address critical knowledge gaps in mosquito control, early diagnosis, and community-based malaria prevention.

The nine-day training will feature public health experts, medical consultants, pharmacists, professors, and researchers from leading healthcare institutions and professional bodies. Facilitators include prominent figures such as Pharm. Ghinsel Nanret Blessing, National Coordinator of GHC, and Prof. Bala Muhammad Audu, former Vice-Chancellor of the Federal University of Health Sciences, Azare. The curriculum will cover malaria awareness, prevention, diagnosis, treatment, and control through structured learning modules and interactive sessions.

The GHC initiative has identified significant knowledge gaps in malaria prevention and control across Nigeria's six geopolitical zones. Outreach activities have exposed a need for sustained health education and youth engagement in efforts to control the disease. The program aims to extend malaria awareness beyond schools by equipping participating students to share accurate health information and promote preventive practices in their families and communities.

Participants who complete the training will receive official certification as recognized GHC Malaria Ambassadors. The Chairman of Geneith Pharmaceuticals and sponsor of the competition, Chief Emmanuel Umenwa, reaffirmed the company's commitment to creating more opportunities for students. He assured that additional operational resources would be deployed to accommodate growing nationwide participation.

The GHC organizers have urged students in junior secondary schools, senior secondary schools, and tertiary institutions who have not registered to take advantage of the reopened portal and participate in Batch B. The initiative seeks to inspire practical action, responsible health decisions, and behavioral change in homes, schools, and communities. By equipping young people with accurate health information, GHC aims to contribute to sustainable malaria control.

The Geneith Health Competition's malaria advocacy campaign has attracted increased participation from schools across Nigeria, necessitating an expansion of the program to accommodate more students. The initiative is expected to make a significant impact in the fight against malaria by mobilizing Nigerian students as advocates and promoting malaria prevention and public health awareness.

Key points

  • Geneith Health Competition expands malaria advocacy campaign to accommodate more students across Nigeria.
  • Nine-day intensive training program begins November 20, 2026, to equip students with knowledge and leadership skills.
  • Initiative aims to address critical knowledge gaps in malaria prevention and control across Nigeria.

Reporting sources

Share this story

Written by

SaharaWire Newsroom
SaharaWire

Reporting for SaharaWire from the Nairobi bureau.